SUBSCRIBE
SUBSCRIBE
News   FDA

India’s Ranbaxy Laboratories’ Gets FDA Nod for Cyclobenzaprine HCL

May 15, 2008 | 
1 min read
MUMBAI, May 15 (Reuters) - Indian drugmaker Ranbaxy Laboratories Ltd has received approval from the U.S. Food and Drug Administration for muscle relaxant cyclobenzaprine hydrochloride tablets, the regulator's website showed.
FDA Approvals Asia
MORE ON THIS TOPIC
Target concept vector illustration. Business goal, marketing strategy, digital aim, bullseye accuracy, cyber challenge, innovation target, focus objective, dart board, internet market.
Phase 3
Taiho and Cullinan’s zipalertinib clears Phase 3, teeing up first-line competition
August 13, 2026
 · 
3 min read
 · 
Gabrielle Masson
Yellow warning sign symbol or alert safety danger caution illustration icon security message and exclamation triangle information icon on attention traffic background with secure alarm. 3D render.
Rare diseases
Deaths reported after treatment with Neurocrine’s approved Prader-Willi drug
August 12, 2026
 · 
3 min read
 · 
Annalee Armstrong
FDA
Replimune finally wins approval, Q2 earnings wrap up, psychedelics stay in spotlight
August 12, 2026
 · 
1 min read
 · 
Jef Akst
Cross icon. Reject, decline concept. Hand Mouse Cursor Clicks the Button. Pointer Push Press
Manufacturing
FDA rejects ITM Isotope’s radiopharma therapy over manufacturing issues
August 11, 2026
 · 
1 min read
 · 
Gabrielle Masson